IDO1 and head and neck squamous cell carcinoma: Consistent with persister enrichment in ICB treated tumors, ATF3 and IDO1 are induced in 4MOSC159 orthotopic syngeneic mouse head and neck squamous cell carcinoma tumors which have regressed during anti-PD-1 treatment (Figures 3G–H and S5A).